AQP7, aquaporin 7, 364

N. diseases: 34; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease BEFREE Mice deficient in the myocyte channel aquaporin 7 (AQP7) show significantly reduced glycerol and ATP contents and develop obesity; however, the influence of AQP7 on cardioplegia effectiveness remains unclear. 31707553 2019
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE AQP7 is expressed in adipose tissue where it facilitates the efflux of glycerol, and AQP7 deficiency has been linked to increased glycerol kinase activity and triglyceride accumulation in adipose tissue, leading to obesity and secondary development of insulin resistance. 29300344 2018
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE The present data suggest the promising therapeutic role of RKs in HF diet-induced obesity that is likely attributable, at least in part, to upregulation of AQP7 expression. 29787773 2018
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE Adipocyte aquaporin 7 (AQP7) expression in lean children and children with obesity. Possible involvement in molecular mechanisms of childhood obesity. 30226208 2018
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease BEFREE Aquaporin 7 (AQP7), a unique glycerol permeable integral membrane protein, has been associated with the onset of obesity. 28489425 2017
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease BEFREE AQP7-deficient mice develop obesity, insulin resistance, and hyperglyceroluria. 22899094 2013
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease BEFREE AQP7 is a glycerol channel in adipose tissue with a suggested role in controlling the accumulation of triglycerides and secondly development of obesity and type-2 diabetes. 23001483 2012
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE AQP7 transcript levels ratio of SAT vs. VAT changed with the presence of obesity and T2D. 20463097 2010
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE The aim of the present work was to evaluate the effect of obesity and type 2 diabetes mellitus (T2DM) on gene expression levels of AQP7 in visceral adipose tissue (VAT) and AQP9 in liver. 18401671 2008
CUI: C0028754
Disease: Obesity
Obesity
0.400 GeneticVariation disease BEFREE We examined whether common single nucleotide polymorphisms (SNPs) in the AQP7 gene modulate the risk of obesity and related abnormalities. 17351148 2007
CUI: C0028754
Disease: Obesity
Obesity
0.400 AlteredExpression disease BEFREE Our objective was to test the hypothesis that AQP7 gene expression levels may be affected by presence of obesity and type 2 diabetes in humans. 17566090 2007
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease BEFREE New studies on AQP7 highlight the important role of glycerol transport in the development of obesity and metabolic disease. 16487720 2006
CUI: C0028754
Disease: Obesity
Obesity
0.400 Biomarker disease CTD_human In summary, our data show that the AQP7 gene is differentially expressed in adipose tissue of lean and obese individuals. 16325777 2006